{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "C",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 is the causal molecule for autosomal-dominant familial Parkinson's disease, and its mutations are linked to neurodegeneration.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly connects LRRK2 mutations to neurodegeneration, establishing the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper uses in vitro kinase assays and knockdown experiments to assess LRRK2's interaction with Akt1.",
          "judgment": "Yes",
          "reasoning": "The assays (kinase activity and protein interaction) are standard techniques for studying kinase function and are relevant to the disease mechanism."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper demonstrates reduced interaction and phosphorylation of Akt1 for disease-associated mutations, but does not explicitly mention controls for the assays.",
          "judgment": "No",
          "reasoning": "The paper does not specify controls (e.g., wild-type vs. mutant) for the assays, but the assays are broadly accepted methods."
        },
        {
          "step_name": "Step 3b: Accepted assay type",
          "extracted_paper_info": "In vitro kinase assays and pull-down experiments are standard techniques for studying kinase activity and protein interactions.",
          "judgment": "Yes",
          "reasoning": "The assays are widely accepted in the field of kinase biology."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The mutations show reduced interaction/phosphorylation of Akt1, which is linked to impaired cell survival, a key pathway in Parkinson's pathology.",
          "judgment": "Yes",
          "reasoning": "The functional defects in Akt1 signaling are directly tied to the pathogenic mechanism."
        }
      ],
      "overall_strength": "PS3_supporting",
      "overall_conclusion": "The reduced interaction and phosphorylation of Akt1 in disease-associated mutations suggest a role in neurodegeneration, supporting pathogenicity."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 mutations are linked to neurodegeneration, and the paper shows reduced interaction with Akt1.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly connects LRRK2 mutations to neurodegeneration, establishing the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper uses in vitro kinase assays and knockdown experiments to assess LRRK2's interaction with Akt1.",
          "judgment": "Yes",
          "reasoning": "The assays (kinase activity and protein interaction) are standard techniques for studying kinase function and are relevant to the disease mechanism."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper demonstrates reduced interaction and phosphorylation of Akt1 for disease-associated mutations, but does not explicitly mention controls for the assays.",
          "judgment": "No",
          "reasoning": "The paper does not specify controls (e.g., wild-type vs. mutant) for the assays, but the assays are broadly accepted methods."
        },
        {
          "step_name": "Step 3b: Accepted assay type",
          "extracted_paper_info": "In vitro kinase assays and pull-down experiments are standard techniques for studying kinase activity and protein interactions.",
          "judgment": "Yes",
          "reasoning": "The assays are widely accepted in the field of kinase biology."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The mutations show reduced interaction/phosphorylation of Akt1, which is linked to impaired cell survival, a key pathway in Parkinson's pathology.",
          "judgment": "Yes",
          "reasoning": "The functional defects in Akt1 signaling are directly tied to the pathogenic mechanism."
        }
      ],
      "overall_strength": "PS3_supporting",
      "overall_conclusion": "The reduced interaction and phosphorylation of Akt1 in disease-associated mutations suggest a role in neurodegeneration, supporting pathogenicity."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "2020"
        },
        "variant_string_id": "LRRK2 I2020T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 is the causal molecule for autosomal-dominant familial Parkinson's disease, and its mutations are linked to neurodegeneration.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly connects LRRK2 mutations to neurodegeneration, establishing the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper uses in vitro kinase assays and knockdown experiments to assess LRRK2's interaction with Akt1.",
          "judgment": "Yes",
          "reasoning": "The assays (kinase activity and protein interaction) are standard techniques for studying kinase function and are relevant to the disease mechanism."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper demonstrates reduced interaction and phosphorylation of Akt1 for disease-associated mutations, but does not explicitly mention controls for the assays.",
          "judgment": "No",
          "reasoning": "The paper does not specify controls (e.g., wild-type vs. mutant) for the assays, but the assays are broadly accepted methods."
        },
        {
          "step_name": "Step 3b: Accepted assay type",
          "extracted_paper_info": "In vitro kinase assays and pull-down experiments are standard techniques for studying kinase activity and protein interactions.",
          "judgment": "Yes",
          "reasoning": "The assays are widely accepted in the field of kinase biology."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The mutations show reduced interaction/phosphorylation of Akt1, which is linked to impaired cell survival, a key pathway in Parkinson's pathology.",
          "judgment": "Yes",
          "reasoning": "The functional defects in Akt1 signaling are directly tied to the pathogenic mechanism."
        }
      ],
      "overall_strength": "PS3_supporting",
      "overall_conclusion": "The reduced interaction and phosphorylation of Akt1 in disease-associated mutations suggest a role in neurodegeneration, supporting pathogenicity."
    }
  ]
}